Keyphrases
Schizophrenia
100%
Metabotropic Glutamate Receptor
100%
Schizophrenic Patients
50%
Prepulse Inhibition
50%
Animal Model of Schizophrenia
50%
Beneficial Effects
50%
Glutamate Release
50%
NMDA Hypofunction
50%
Brain Regions
25%
Human Subjects
25%
Schizophrenia Treatment
25%
Pathophysiology
25%
Psychosis
25%
Pharmacotherapy
25%
MK-801
25%
Drug Development
25%
Novel Treatments
25%
Second-generation Antipsychotics
25%
Glutamate
25%
MGluR
25%
Brain Processes
25%
Metabotropic Receptors
25%
Receptor Modulators
25%
MGluR5 Antagonist
25%
Neuroscience
Glutamate Receptor
100%
Receptor
100%
Glutamic Acid
75%
Prepulse Inhibition
50%
N-Methyl-D-Aspartic Acid
50%
Metabotropic Receptor
50%
Treatment of Schizophrenia
25%
Agonist
25%
Metabotropic Glutamate Receptor
25%
Drug Therapy
25%
Pharmacology, Toxicology and Pharmaceutical Science
Glutamate Receptor
100%
Receptor
100%
Glutamic Acid
75%
N Methyl Dextro Aspartic Acid
50%
Metabotropic Receptor
50%
Drug Development
25%
Pharmacotherapy
25%
Pathophysiology
25%
Prematurity
25%
Preclinical Study
25%
Homo sapiens
25%